Parkside Financial Bank & Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.23M | Sell |
28,631
-683
| -2% | -$152K | 0.48% | 36 |
|
|
2025
Q4 | $6.7M | Sell |
29,314
-117
| -0.4% | -$26.7K | 0.5% | 34 |
|
|
2025
Q3 | $6.81M | Buy |
29,431
+676
| +2% | +$138K | 0.53% | 31 |
|
|
2025
Q2 | $5.34M | Buy |
28,755
+9,381
| +48% | +$1.74M | 0.57% | 34 |
|
|
2025
Q1 | $4.06M | Buy |
19,374
+2,061
| +12% | +$401K | 0.52% | 35 |
|
|
2024
Q4 | $3.08M | Buy |
17,313
+394
| +2% | +$72.4K | 0.41% | 49 |
|
|
2024
Q3 | $3.34M | Buy |
16,919
+594
| +4% | +$111K | 0.47% | 45 |
|
|
2024
Q2 | $2.8M | Sell |
16,325
-27
| -0.2% | -$4.47K | 0.44% | 48 |
|
|
2024
Q1 | $2.98M | Buy |
16,352
+1,054
| +7% | +$182K | 0.48% | 42 |
|
|
2023
Q4 | $2.37M | Buy |
15,298
+3,698
| +32% | +$539K | 0.43% | 49 |
|
|
2023
Q3 | $1.73M | Buy |
11,600
+1,540
| +15% | +$226K | 0.4% | 46 |
|
|
2023
Q2 | $1.36M | Buy |
10,060
+1,116
| +12% | +$164K | 0.32% | 56 |
|
|
2023
Q1 | $1.43M | Sell |
8,944
-2,656
| -23% | -$406K | 0.38% | 48 |
|
|
2022
Q4 | $1.87M | Buy |
11,600
+3,093
| +36% | +$474K | 0.54% | 36 |
|
|
2022
Q3 | $1.14M | Sell |
8,507
-190
| -2% | -$27.3K | 0.36% | 50 |
|
|
2022
Q2 | $1.33M | Buy |
8,697
+242
| +3% | +$37K | 0.41% | 43 |
|
|
2022
Q1 | $1.37M | Buy |
8,455
+745
| +10% | +$108K | 0.37% | 43 |
|
|
2021
Q4 | $1.04M | Sell |
7,710
-927
| -11% | -$110K | 0.26% | 68 |
|
|
2021
Q3 | $932K | Sell |
8,637
-5,036
| -37% | -$575K | 0.27% | 54 |
|
|
2021
Q2 | $1.54M | Buy |
13,673
+47
| +0.3% | +$5.29K | 0.45% | 34 |
|
|
2021
Q1 | $1.47M | Buy |
13,626
+282
| +2% | +$30.2K | 0.45% | 38 |
|
|
2020
Q4 | $1.43M | Sell |
13,344
-487
| -4% | -$46.8K | 0.45% | 36 |
|
|
2020
Q3 | $1.21M | Buy |
13,831
+661
| +5% | +$62.2K | 0.42% | 39 |
|
|
2020
Q2 | $1.29M | Buy |
13,170
+2,443
| +23% | +$215K | 0.42% | 38 |
|
|
2020
Q1 | $817K | Buy |
10,727
+622
| +6% | +$53K | 0.31% | 50 |
|
|
2019
Q4 | $895K | Buy |
10,105
+361
| +4% | +$30K | 0.26% | 56 |
|
|
2019
Q3 | $738K | Buy |
9,744
+290
| +3% | +$19.9K | 0.24% | 66 |
|
|
2019
Q2 | $688K | Buy |
9,454
+74
| +0.8% | +$5.82K | 0.22% | 67 |
|
|
2019
Q1 | $755K | Sell |
9,380
-2,161
| -19% | -$177K | 0.25% | 62 |
|
|
2018
Q4 | $1.06M | Buy |
11,541
+714
| +7% | +$62.8K | 0.38% | 40 |
|
|
2018
Q3 | $1.02M | Sell |
10,827
-724
| -6% | -$68.7K | 0.36% | 42 |
|
|
2018
Q2 | $1.07M | Sell |
11,551
-424
| -4% | -$41.4K | 0.4% | 43 |
|
|
2018
Q1 | $1.13M | Sell |
11,975
-288
| -2% | -$31.6K | 0.43% | 38 |
|
|
2017
Q4 | $1.19M | Sell |
12,263
-44
| -0.4% | -$4.15K | 0.43% | 41 |
|
|
2017
Q3 | $1.09M | Buy |
12,307
+10
| +0.1% | +$761 | 0.43% | 41 |
|
|
2017
Q2 | $891K | Sell |
12,297
-233
| -2% | -$15.7K | 0.37% | 52 |
|
|
2017
Q1 | $817K | Buy |
12,530
+2,271
| +22% | +$143K | 0.35% | 52 |
|
|
2016
Q4 | $642K | Sell |
10,259
-6
| -0.1% | -$366 | 0.28% | 69 |
|
|
2016
Q3 | $647K | Sell |
10,265
-346
| -3% | -$22.4K | 0.3% | 67 |
|
|
2016
Q2 | $657K | Buy |
10,611
+15
| +0.1% | +$914 | 0.32% | 65 |
|
|
2016
Q1 | $605K | Sell |
10,596
-2,119
| -17% | -$118K | 0.3% | 67 |
|
|
2015
Q4 | $753K | Sell |
12,715
-265
| -2% | -$15.3K | 0.37% | 51 |
|
|
2015
Q3 | $706K | Sell |
12,980
-3,787
| -23% | -$247K | 0.4% | 49 |
|
|
2015
Q2 | $1.13M | Buy |
16,767
+796
| +5% | +$52K | 0.6% | 42 |
|
|
2015
Q1 | $935K | Buy |
15,971
+90
| +0.6% | +$5.44K | 0.5% | 48 |
|
|
2014
Q4 | $1.04M | Sell |
15,881
-2,426
| -13% | -$153K | 0.58% | 44 |
|
|
2014
Q3 | $1.06M | Buy |
18,307
+21
| +0.1% | +$1.17K | 0.64% | 44 |
|
|
2014
Q2 | $1.03M | Sell |
18,286
-18
| -0.1% | -$944 | 0.61% | 50 |
|
|
2014
Q1 | $941K | Sell |
18,304
-96
| -0.5% | -$4.85K | 0.59% | 54 |
|
|
2013
Q4 | $971K | Sell |
18,400
-1,010
| -5% | -$49.6K | 0.66% | 46 |
|
|
2013
Q3 | $868K | Sell |
19,410
-2,036
| -9% | -$90.3K | 0.68% | 46 |
|
|
2013
Q2 | $887K | Buy |
+21,446
| New | +$938K | 0.7% | 44 |
|
Other funds holding ABBV
Parkside Financial Bank & Trust's ABBV Position: Q1 2026 in Review
Parkside Financial Bank & Trust reduced its AbbVie (ABBV) stake by 2.3% in Q1 2026, selling an estimated $152K and leaving 28,631 shares worth $6.23M. The position accounts for 0.48% of the portfolio, ranked #36.
Parkside Financial Bank & Trust first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.81M in Q3 2025. 4,102 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Parkside Financial Bank & Trust held 28,631 shares of AbbVie worth $6.23M as of Q1 2026.
- Parkside Financial Bank & Trust sold 683 AbbVie shares in Q1 2026, an estimated $152K.
- AbbVie made up 0.48% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #36 holding.
- Parkside Financial Bank & Trust first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Parkside Financial Bank & Trust's AbbVie position peaked at $6.81M in Q3 2025.
- 4,102 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.